Among the clinical cohort (n = 360), ROR1 expression level was significantly associated with tumour grade (p = 0.013) and International Federation of Gynecology and Obstetrics (FIGO) stage (p = 0.030) (Fig. 2A,C). This evidence concerns the gene ROR1 and neoplasm.